Constitutive and inducible expression of SKALP/elafin provides anti- elastase defense in human epithelia

Journal of Clinical Investigation

Volumn 98, Issue 6, 1996, Pages 1389-1399

  Pfundt, Rolph ^a   Van Ruissen, Fred ^a   Van Vlijmen Willems, Ivonne M J J ^a   Alkemade, Hans A C ^a   Zeeuwen, Patrick L J M ^a   Jap, Paul H ^a   Dijkman, Henri ^a   Fransen, Jack ^a   Croes, Huib ^a   Van Erp, Piet E J ^a   Schalkwijk, Joost ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

elastase; epidermis; epithelium; polymorphonuclear leukocyte; proteinase inhibitor

Indexed keywords

ELAFIN; ELASTASE;

ANIMAL TISSUE; ARTICLE; CELL STIMULATION; COMPLEMENT ACTIVATION; CROSS LINKING; EPIDERMIS; EPITHELIUM CELL; FETOPLACENTAL UNIT; HUMAN; IMMUNOELECTRON MICROSCOPY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEINASE INHIBITION; RECEPTOR DOWN REGULATION;

EID: 10144262543     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118926     Document Type: Article

References (40)

1. Calkins, C.C., and B.F. Sloane. 1995. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol. Chem. Hoppe Seyler 376:71-80.
2. Murphy, G., and A.J. Docherty. 1992. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7:120-125.
3. Vogelmeier, C., R.C. Hubbard, G.A. Fells, H.P. Schnebli, R.C. Thompson, H. Fritz, and R.G. Crystal. 1991. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Invest 87:482-488.
4. Schalkwijk, J., A. Chang, P. Janssen, G.J. de Jongh, and P.D. Mier. 1990. Skin-derived antileucoproteinases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis. Br. J. Dermatol. 122:631-641.
5. Wiedow, O., J. Schröder, H. Gregory, J.A. Young, and E. Christophers. 1990. Elafin: an elastase specific inhibitor of human skin. Purification characterization and complete amino acid sequence. J. Biol. Chem. 265:14791-14795.
6. Molhuizen, H.O.F., H.A.C. Alkemade, P.L.J.M. Zeeuwen, G.J. de Jongh, B. Wieringa, and J. Schalkwijk. 1993. SKALP/Elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence and evidence for transglutaminase crosslinking. J. Biol. Chem. 268:12028-12032.
7. Sallenave, J.M., and A. Silva. 1993. Characterization and gene sequence of the precursor of elafin: an elastase-specific inhibitor in bronchial secretions. Am. J. Respir. Cell Mol. Biol. 8:439-445.
8. Zhang, M., Z. Zou, N. Maass, and R. Sager. 1995. Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res. 55:2537-2541.
9. Wiedow, O., J. Lüdemann, and B. Utecht. 1991. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174:6-10.
10. Schalkwijk, J., I.M.J.J. van Vlijmen-Willems, J.A.C. Alkemade, and G.J. de Jongh. 1993. Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J. Invest. Dermatol. 100:390-393.
11. Alkemade, J.A.C. H.O.F. Molhuizen, M. Ponec, J.A. Kempenaar, P.L.J.M. Zeeuwen, G.J. de Jongh, I.M.J.J. van Vlijmen-Willems, P.E.J. van Erp, P.C.M. van de Kerkhof, and J. Schalkwijk. 1994. SKALP/Elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J. Cell Sci. 107: 2335-2342.
12. Saheki, T., F. Ito, H. Hagiwara, Y. Saito, J. Kuroki, S. Tachibana, and S. Hirose. 1992. Primary structure of the human elafin precursor preproelafin deduced from the nucleotide sequence of ils gene and the presence of unique repetitive sequences in the prosegment. Biochem. Biophys. Res. Commun. 185:240-245.
13. Molhuizen, H.O.F., P.L.J.M. Zeeuwen, D. Olde Weghuis, A. Geurts van Kessel, and J. Schalkwijk. 1994. Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-q13.Cytogenet. Cell Genet. 66:129-131.
14. Steinert, P.M., and L.N. Marekov. 1995. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem. 270:17702-17711.
15. Watt, F.M. 1989. Terminal differentiation of epidermal keratinocytes. Curr. Opin. Cell Biol 1:1107-1115.
16. Fuchs, E. 1990. Epidermal differentiation: the bare essentials. J. Cell Biol. 111:2807-2814.
17. Kuijpers, A.L.A., J.A.C. Alkemade, P.C.M. van de Kerkhof, and J. Schalkwijk. 1996. Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation. Arch. Dermatol. Res. In press.
18. Nara, K., S. Ito, T. Ito, Y. Suzuki, M.A. Ghoneim, S. Tachibana, and S. Hirose. 1994. Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed "cementoin". J. Biochem. (Tokyo). 115:441-448.
19. Schalkwijk, J., C. de Roo, and G.J. de Jongh. 1991. Skin-derived antileukoproteinase (SKALP) an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochim. Biophys. Acta 1096:148-154.
20. van Duijnhoven, J.L.P., J. Schalkwijk, M.H.G.C. Kranenborg, I.M.J.J. van Vlijmen-Willems, A. Groeneveld, P.E.J. van Erp, E.D.J. Timmer, G.J. de Jongh, and W.J.M. van de Ven. 1992. MON-150, a versatile monoclonal antibody against involucrin; characterization and applications. Arch. Dermatol. Res. 284:167-172.
21. Sambrook, J., E.F. Fritch, and T. Maniatis. 1989. Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 7.43 pp.
22. Rheinwald, J.G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell. 6:331-344.
23. van Ruissen, F., P.E.J. van Erp, G.J. de Jongh, J.B.M. Boezeman, P.C.M. van de Kerkhof, and J. Schalkwijk. 1994. Cell kinetic characterization of growth arrest in cultured human keratinocytes. J. Cell Sci. 107:2219-2228.
24. Poumay, Y., and M.R. Pittelkow. 1995. Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J. Invest. Dermatol. 104:271-276.
25. Schrijver, G., J. Schalkwijk, J.C. Robben, K.J. Assmann, and R.A. Koene. 1989. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J. Exp. Med. 169:1435-1448.
26. Reibel, J., H. Clausen, B.A. Dale, and S.M. Thacher. 1989. Immunohistochemical analysis of stratum corneum components in oral squamous epithelia. Differentiation. 41:237-244.
27. Holbrook, K.A. 1991. Structure and function of the developing human skin. In Physiology. Biochemistry and Molecular Biology of the Skin. L.A. Goldsmith, editor. Oxford University Press, New York. 63-112.
28. Dale, B.A., K.A. Holbrook, J.R. Kimball, M. Hoff, and T.T. Sun. 1985. Expression of epidermal keratins and filaggrin during human fetal skin development. J. Cell Biol. 101:1257-1269.
29. van Ruissen, F., G.J. de Jongh, P.L.J.M. Zeeuwen, P.E.J. van Erp, P. Madsen, and J. Schalkwijk. 1996. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J. Cell Physiol. 168:442-452.
30. Weiss, R.A., R. Eichner, and T.T. Sun. 1984. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56- kDalton keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol. 98:1397-1406.
31. Mansbridge, J.N., and A.M. Knapp. 1987. Changes in keratinocyte maturation during wound healing. J. Invest. Dermatol. 89:253-263.
32. Weiss, S.J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
33. Campbell, E.J., and M.A. Campbell. 1988. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J. Cell Biol. 106:667-676.
34. Owen, C.A., M.A. Campbell, P.L. Sannes, S.S. Boukedes, and E.J. Campbell. 1995. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131:775-789.
35. Katayama, H., T. Hase, and H. Yaoita. 1994. Detachment of cultured normal human keratinocytes by contact with TNF alpha-stimulated neutrophils in the presence of platelet-activating factor. J. Invest. Dermatol. 103:187-190.
36. Nakamura, T.Y., I. Yamamoto, H. Nishitani, T. Matozaki, T. Suzuki, S. Wakahayashi, M. Shigekawa, and K. Goshima. 1995. Detachment of cultured cells from the substratum induced by the neutrophil-derived oxidant NH2Cl: synergistic role of phosphotyrosine and intracellular Ca2+ concentration. J. Cell Biol. 131:509-524.
37. Badinga, L., F.J. Michel, M.J. Fields, D.C. Sharp, and R.C. Simmen. 1994. Pregnancy-associated endometrial expression of antileukoproteinase gene is correlated with epitheliochorial placentation. Mol. Reprod. Dev. 38: 357-363.
38. Nonomura, K., K. Yamanishi, H. Yasuno, K. Nara, and S. Hirose. 1994. Up-regulation of elafin/SKALP gene expression in psoriatic epidermis. J. Invest. Dermatol. 103:88-91.
39. Sallenave, J.-M., J. Schulmann, J. Crossley, M. Jordana, and J. Gauldie. 1994. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 11:(6)733-741.
40. Perlmutter, D.H., J. Travis, and P.I. Punsal. 1988. Elastase regulates the synthesis of its inhibitor, α1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZα1 PI deficiency. J. Clin. Invest. 81:1774-1780.